Article Information
History
- July 1, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Salah Sommakia1,
- Naredos H. Almaw1,
- Sandra H. Lee1,
- Dinesh K. A. Ramadurai1,
- Iosef Taleb1,
- Christos P. Kyriakopoulos1,
- Chris J. Stubben2,
- Jing Ling1,
- Robert A. Campbell3,
- Rami A. Alharethi4,
- William T. Caine4,
- Sutip Navankasattusas1,
- Guillaume L. Hoareau1,5,
- Anu E. Abraham6,
- James C. Fang6,
- Craig H. Selzman4,
- Stavros G. Drakos1,6 and
- Dipayan Chaudhuri1,6,*
- 1Nora Eccles Harrison Cardiovascular Research and Training Institute, University of Utah, Salt Lake City, UT, USA
- 2Bioinformatics Shared Resource, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112
- 3Department of Internal Medicine, Division of General Medicine, Program in Molecular Medicine, University of Utah, Salt Lake City, UT, USA
- 4U.T.A.H. (Utah Transplant Affiliated Hospitals) Cardiac Transplant Program: University of Utah Healthcare and School of Medicine, Intermountain Medical Center, Salt Lake Veterans Affairs Health Care System, Salt Lake City, UT
- 5Emergency Medicine Division, Department of Surgery, University of Utah, Salt Lake City, UT, USA
- 6Department of Internal Medicine, Division of Cardiovascular Medicine, University of Utah, Salt Lake City, UT
- ↵*Correspondence: Dipayan Chaudhuri, 95 South 2000 East, CVRTI (Building 500), Salt Lake City, UT 84112, dipayan.chaudhuri{at}hsc.utah.edu, 801-585-3682
Posted July 01, 2021.
FGF21 defines a potential cardio-hepatic signaling circuit in human heart failure
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos